Clinical Trials Browser

Psychological Well-Being, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Kidney Neoplasms, Leukemia, Liver Neoplasms, Lymphoma, Non-Hodgkin, Melanoma, Motor Activity, Mouth Neoplasms, Neoplasms, Obesity, Pancreatic Neoplasms, Pharyngeal Neoplasms, Rectal Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Weight Loss, Endometrial Neoplasms, Overweight

NCT04789018 2025-10-10

Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

Active not recruiting

118 enrolled

Genitourinary

Prostatic Neoplasms

NCT03880422 2025-10-02

Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors

Phase NA Recruiting

50 enrolled

GenitourinaryOther

Obesity, Prostatic Neoplasms, Overweight

NCT06049355 2025-05-29

EMBRACE: Exercising Together

Phase 2 Recruiting

400 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT05627219 2025-05-20

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT05588700 2025-02-17

STARTER

Phase NA Recruiting

236 enrolled

Genitourinary

Fatigue, Testicular Neoplasms

NCT05214937 2024-12-04

A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

Phase NA Recruiting

120 enrolled

Genitourinary

Motor Activity, Prostatic Neoplasms, Sedentary Behavior

NCT04548193 2024-08-28

Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship

Phase 1 Completed

49 enrolled 12 charts

Genitourinary

Urinary Bladder Neoplasms

NCT02408406 2024-06-27

PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers

Phase NA Completed

140 enrolled

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasms, Colorectal Neoplasms

NCT06044220 2023-09-25

Testicular Self-examination Training Given to Students

Phase NA Completed

100 enrolled

Genitourinary

Testicular Neoplasms

NCT05054296 2023-03-29

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Phase 2 Recruiting

200 enrolled

Genitourinary

Prostatic Neoplasms

NCT02811952 2022-10-14

Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients

Completed

100 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02419846 2022-07-25

Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program

Phase NA Terminated

319 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT02298998 2021-06-14

Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study

Completed

41 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02168062 2020-07-23

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

Phase 2 Terminated

57 enrolled 27 charts

Genitourinary

Prostate Adenocarcinoma

NCT04222374 2020-07-13

Uro-DNA - GWAS

Completed

200 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01846520 2020-01-23

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Phase NA Completed

200 enrolled

GastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT02477137 2018-08-31

PhONEME

Phase NA Completed

150 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

COMPETENCE

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Long-Term Follow-Up in Patients With Prostate Cancer After Surgery

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Addressing Health Literacy With a Tailored Survivorship Care Plan

BETR-PC

AYAConnect

Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors

EMBRACE: Exercising Together

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

STARTER

A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship

PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers

Testicular Self-examination Training Given to Students

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients

Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program

Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

Uro-DNA - GWAS

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

PhONEME